ERcast: Clinical Perspectives Podcast Preview
The summary below is from an episode of ERcast: Clinical Perspectives
The Glasgow Blatchford Score helps risk-stratify suspected upper GI bleeding before endoscopy. In non-variceal UGIB, a GBS of 0-2 identifies a very low-risk group for rebleeding and short-term mortality, while possible variceal bleeding remains a separate, higher-risk problem.
Glasgow Blatchford Score in UGIB
- Low-risk non-variceal group: In suspected non-variceal upper GI bleeding, a Glasgow Blatchford Score of 0-2 identified patients with extremely low short-term risk and essentially no 30-day mortality in this cohort.
- Rebleeding signal: Thirty-day rebleeding was rare in the low-risk non-variceal group, around 2%, supporting selective outpatient management rather than routine admission for every suspected bleed.
- Variceal bleed exception: Possible variceal bleeding is different: mortality and rebleeding were much higher, and the score was not used to label these patients low risk. We get into that separation in the episode.
- History limitation: Cirrhosis history alone is an unreliable shortcut for excluding variceal hemorrhage, since many variceal bleeds present without a known cirrhosis diagnosis.
- Practice-changing threshold: The key bedside move is recognizing that GBS 0-2 may be low enough for discharge planning in the right non-variceal patient, a threshold supported by this study and multiple guidelines.
Subscribe to ERcast: Clinical Perspectives to listen to the episode.
Faculty
- Matthew DeLaney, MD, FACEP, FAAEM
Dr. Matthew DeLaney is an emergency medicine physician and educator based in Birmingham, Alabama. A native of Mobile, he earned his medical degree from the University of South Alabama and completed his emergency medicine residency at Maine Medical Center.Dr. DeLaney has experience in both community and academic emergency medicine and is known for his commitment to teaching and medical education. He lives in Birmingham with his wife, Erin, who is also a physician, and their two daughters.
- Salim Rezaie, MD